Elevance Health, Inc. ELV
Elevance Health, Inc. (ELV) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.78% (safety: safe). FY2025 revenue was $199.1B at a 2.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-17 | Leerink Partners | Market Perform (main) |
| 2026-07-16 | RBC Capital | Sector Perform (main) |
| 2026-07-16 | Wells Fargo | Overweight (main) |
| 2026-07-16 | Guggenheim | Buy (main) |
| 2026-07-16 | Barclays | Overweight (main) |
| 2026-07-16 | Baird | Neutral (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.181 |
| Retained earnings / assets | 0.291 |
| EBIT / assets | 0.059 |
| Equity / liabilities | 0.568 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | 6/9 | 3.13 | 15.2 | +12.5% |
| CNC | CENTENE CORP | 4/9 | 0.38 | — | +19.4% |
| HUM | HUMANA INC | 5/9 | 5.1 | 38.8 | +10.1% |
| CI | Cigna Group | 7/9 | 1.4 | 12.6 | +11.2% |
| MOH | MOLINA HEALTHCARE, INC. | 4/9 | 3.6 | 25.4 | +11.7% |
| OSCR | Oscar Health, Inc. | 4/9 | -2.18 | — | +27.5% |
| ALHC | Alignment Healthcare, Inc. | 5/9 | -0.35 | — | +46.1% |
All Finance, Insurance & Real Estate companies →
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
FAQ
Is ELV financially healthy?
Elevance Health, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ELV pay a dividend, and is it safe?
Yes. Elevance Health, Inc. pays a dividend yielding about 1.78% with a 27.0% payout ratio, rated “safe” for safety.
How profitable is ELV?
In FY2025, Elevance Health, Inc. had a net margin of 2.8% and a return on equity of 12.9%.
Is ELV overvalued or undervalued?
Elevance Health, Inc. trades at about 15.8× trailing earnings — near its 10-year norm (10-year range 13.7×–21.4×, median 17.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for ELV?
The average Wall-Street price target for Elevance Health, Inc. is $449.10, about 12.5% above the recent price, from 21 analysts (consensus: buy).
Is ELV a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Elevance Health, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 15.2×, a dividend yield of 1.78%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.